Forte Biosciences, Inc. 4 SEC Filings

Filed On	Filing
27 Aug 2026	Form 4: Doberstein Stephen K, Director Disposed of 37,000 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 18,353 Restricted Stock Units (Disposition to Issuer)
27 Aug 2026	Form 4: Finck Barbara K, Director Disposed of 42,000 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 166 Stock Option (right to buy)] (Disposition to Issuer) · Disposed of 18,353 Restricted Stock Units (Disposition to Issuer)
27 Aug 2026	Form 4: Kapoor Shivpreet Singh, Director Disposed of 33,000 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 18,353 Restricted Stock Units (Disposition to Issuer)
27 Aug 2026	Form 4: Brun Scott C., Director Disposed of 36,000 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 18,353 Restricted Stock Units (Disposition to Issuer)
27 Aug 2026	Form 4: Kornfeld Steven, Director Disposed of 3,960 shares (Tender Offer) · Disposed of 38,000 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 18,353 Restricted Stock Units (Disposition to Issuer)
27 Aug 2026	Form 4: Gryska David W, Director Disposed of 5,940 shares (Tender Offer) · Disposed of 34,000 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 2,000 Stock Option (right to buy)] (Disposition to Issuer) · 1 more
27 Aug 2026	Form 4: Vincent Richard G, Director Disposed of 33,000 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 18,353 Restricted Stock Units (Disposition to Issuer)
27 Aug 2026	Form 4: Riley Antony A, CHIEF FINANCIAL OFFICER Disposed of 42,600 shares (Tender Offer) · Disposed of 457,119 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 63,726 Restricted Stock Units (Disposition to Issuer)
27 Aug 2026	Form 4: Wagner Paul A., Director Disposed of 85,482 shares (Tender Offer) · Disposed of 1,768,265 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 186,011 Restricted Stock Units (Disposition to Issuer)
06 Jul 2026	Form 4: Riley Antony A, CHIEF FINANCIAL OFFICER Received 375 shares by exercise or conversion · Gave up 134 shares to cover exercise price or tax ($2.86K)
06 Jul 2026	Form 4: Wagner Paul A., Director Received 1,250 shares by exercise or conversion · Gave up 98 shares to cover exercise price or tax ($2.09K)
17 Jun 2026	Form 4: Riley Antony A, CHIEF FINANCIAL OFFICER Granted 22,000 Stock Option (right to buy)
17 Jun 2026	Form 4: Wagner Paul A., Director Granted 500,000 Stock Option (right to buy)
02 Jun 2026	Form 4: Doberstein Stephen K, Director Granted 18,353 Restricted Stock Units
02 Jun 2026	Form 4: Kapoor Shivpreet Singh, Director Granted 18,353 Restricted Stock Units
02 Jun 2026	Form 4: Vincent Richard G, Director Granted 18,353 Restricted Stock Units
02 Jun 2026	Form 4: Gryska David W, Director Granted 18,353 Restricted Stock Units
02 Jun 2026	Form 4: Brun Scott C., Director Granted 18,353 Restricted Stock Units
02 Jun 2026	Form 4: Kornfeld Steven, Director Granted 18,353 Restricted Stock Units
03 Apr 2026	Form 4: Riley Antony A, CHIEF FINANCIAL OFFICER Received 375 shares by exercise or conversion · Gave up 134 shares to cover exercise price or tax ($3.33K)

Comments